-
Covid vaccines ‘highly effective’ against B1.617.2 variant: Study
A new study by health officials in England shows for the first time that two doses of Covid-19 vaccines are “highly effective” against the B1.617.
-
Covid-19 vaccine: Family members of employees eligible for vaccination at workplaces
Many companies, both public and private, have already announced vaccination drives for employees and their dependents
-
Tech students develop Telegram bot to notify available slots to get Covid vaccine
The Telegram bot, CoWIN alerts, developed by students of Indraprastha Institute of Information Technology in Delhi was launched in May and has amassed
-
Nearly 2 crore Covid-19 vaccine doses available with states, UTs: Centre
Furthermore, nearly 26 lakh vaccine doses are in the pipeline and will be received by the states and UTs within the next three days, the Union health
-
Vaccines to all adults by end of year; need to focus on peri-urban, rural areas: Vardhan
Union Health Minister Harsh Vardhan said that 51 crore Covid-19 vaccine doses will be made available by July and 216 crore more between August and Dec
-
Vaccination should be taken 3 months after recovery from Covid-19: Health ministry
These recommendations have been based on the evolving situation of the Covid-19 pandemic and emerging global scientific evidence and experience, the h
-
Wipro expects to access about one lakh doses of Covid-19 vaccine for employees
The Bengaluru-based company said it has partnered with top-tier hospitals and a tech-enabled online-to-offline delivery platform to provide Covid-19 v
-
More pharma firms should be allowed to make vaccine: Nitin Gadkari
There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield
-
Centre says Covid-19 pandemic is shrinking, warns 98% of population still vulnerable
We have been able to contain the spread to under 2% of the population due to continued efforts by the medical fraternity, states and districts, Lav Ag
-
We continue to scale up Covid-19 vaccine manufacturing and prioritise India: SII
The Serum Institute of India said it will start export of Covid-19 vaccine by year-end
